November 25, 2019
1 min read
Save
This article is more than 5 years old. Information may no longer be current.
Canada recommends Verkazia reimbursement
The Canadian Drug Expert Committee has issued a reimbursement recommendation for Verkazia eye drops, a treatment for severe vernal keratoconjunctivitis, according to a press release.
Verkazia (cyclosporine 0.1% topical ophthalmic emulsion, Santen) is indicated for children from the age of 4 years through adolescence.
The final decision on public reimbursement will be made by provincial jurisdictions, the release said.